FDA NDC Directory · JSON-LD · Markdown

Bismuth subcitrate potassium, Metronidazole, Tetracycline hydrochloride

NDC 50742-283 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerIngenus Pharmaceuticals, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA217511
Dosage form / routeCAPSULE · ORAL
Active ingredientsBISMUTH SUBCITRATE POTASSIUM (140 mg/1)
METRONIDAZOLE (125 mg/1)
TETRACYCLINE HYDROCHLORIDE (125 mg/1)
Marketing started20230704
Package count1

External sources

Source: openFDA. Public-domain (CC0).